Cargando…
Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines
In an ongoing multinational trial, we obtained blood samples from 365 volunteers vaccinated with mRNA vaccines (Moderna, BioNTech), viral DNA-vectored vaccines (AstraZeneca, Sputnik-V, and Johnson and Johnson), or the attenuated virus vaccine from Sinopharm. After collecting reactogenicity data, the...
Autores principales: | Adjobimey, Tomabu, Meyer, Julia, Sollberg, Leander, Bawolt, Michael, Berens, Christina, Kovačević, Peđa, Trudić, Anika, Parcina, Marijo, Hoerauf, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254618/ https://www.ncbi.nlm.nih.gov/pubmed/35799790 http://dx.doi.org/10.3389/fimmu.2022.917905 |
Ejemplares similares
-
Comparison of AstraZeneca and sinopharm vaccines as boosters in protection against COVID-19 infection
por: Letafati, Arash, et al.
Publicado: (2023) -
Side effects of Sputnik V, Oxford–AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran
por: Oghazian, Sahar, et al.
Publicado: (2023) -
Stevens-Johnson Syndrome Following ChAdOx1 nCoV-19 Vaccination (AstraZeneca)
por: Lee, Hyo Jin, et al.
Publicado: (2023) -
A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca
por: Boshra, Marian S., et al.
Publicado: (2022) -
Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021)
por: Razazian, Nazanin, et al.
Publicado: (2023)